Zobrazeno 1 - 10
of 88
pro vyhledávání: '"cancer cell membranes"'
Autor:
Yunqi Guo, Zhiqiang Wang, Gaoming Li, Mengsi Zhan, Tingting Xiao, Jianhong Wang, Jan C.M. van Hest, Xiangyang Shi, Mingwu Shen
Publikováno v:
Bioactive Materials, Vol 43, Iss , Pp 129-144 (2025)
Construction of a cancer nanovaccine that can simultaneously activate immune cells and exert efficient tumor treatment still remains a challenge. Herein, we showcase a proof-of-concept demonstration of an advanced therapeutic nanovaccine formulation
Externí odkaz:
https://doaj.org/article/e4d2aa4f7c3a4433966b9a064be86a7c
Autor:
Yutao Zou, Junjie Wu, Qiuyun Zhang, Jiayi Chen, Xuanxuan Luo, Yijie Qu, Rui Xia, Weiqi Wang, Xiaohua Zheng
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Porphyrins-based nanoscale metal-organic frameworks (nMOFs) has been widely utilized to kills tumor cells by generating cytotoxic reactive oxygen species (ROS). However, porphyrin based nMOFs (por-nMOFs) still face challenges such as rapid immune cle
Externí odkaz:
https://doaj.org/article/82dde5277bf9445bbc43c1b975c49c5b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xiaoying Li, Yanzi Yu, Qi Chen, Jiabao Lin, Xueqiong Zhu, Xiaoting Liu, Lizhen He, Tianfeng Chen, Weiling He
Publikováno v:
Journal of Nanobiotechnology, Vol 20, Iss 1, Pp 1-16 (2022)
Abstract Background Cancer cell membrane-camouflaged nanotechnology for metal complex can enhance its biocompatibility and extend the effective circulation time in body. The ruthenium polypyridyl complex (RuPOP) has extensive antitumor activity, but
Externí odkaz:
https://doaj.org/article/8b51f7387a664baf8f570486e3e17bc0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Exploration, Vol 2, Iss 1, Pp n/a-n/a (2022)
Abstract For efficient cancer theranostics, surface modification of nanomaterials plays an important role in improving targeting ability and reducing the non‐specific interactions with normal tissues. Recently, the biomimetic technology represented
Externí odkaz:
https://doaj.org/article/f76e6fbdc7e0408b8209ae93415f5202
Autor:
Hanyi Fang, Yongkang Gai, Sheng Wang, Qingyao Liu, Xiao Zhang, Min Ye, Jianling Tan, Yu Long, Kuanyin Wang, Yongxue Zhang, Xiaoli Lan
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-14 (2021)
Abstract Background Triple-negative breast cancer (TNBC) is a kind of aggressive breast cancer with a high rate of metastasis, poor overall survival time, and a low response to targeted therapies. To improve the therapeutic efficacy and overcome the
Externí odkaz:
https://doaj.org/article/5c9abab0f88a4d8d899dd1b3ce942851
Autor:
Mengyu Chen, Yuexin Cui, Wenyan Hao, Yueyue Fan, Jingqiu Zhang, Qianqian Liu, Mingrui Jiang, Yang Yang, Yingzi Wang, Chunsheng Gao
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 2241-2255 (2021)
The main treatment measure currently used for glioma treatment is chemotherapy; the biological barrier of solid tumors hinders the deep penetration of nanomedicines and limits anticancer therapy. Furthermore, the poor solubility of many chemotherapeu
Externí odkaz:
https://doaj.org/article/f486ac590c2e445ebece74cd6dd9c115
Autor:
Hanyi Fang, Mengting Li, Qingyao Liu, Yongkang Gai, Lujie Yuan, Sheng Wang, Xiao Zhang, Min Ye, Yongxue Zhang, Mingyuan Gao, Xiaoli Lan, Yi Hou
Publikováno v:
Nano-Micro Letters, Vol 12, Iss 1, Pp 1-14 (2020)
Abstract Triple-negative breast cancer (TNBC) is a subtype of breast cancer in which the estrogen receptor and progesterone receptor are not expressed, and human epidermal growth factor receptor 2 is not amplified or overexpressed either, which make
Externí odkaz:
https://doaj.org/article/98c644709b674626b40115c9456e12b4
Autor:
Junbin Gao, Fei Wang, Shuanghu Wang, Lu Liu, Kun Liu, Yicheng Ye, Zhen Wang, Hong Wang, Bin Chen, Jiamiao Jiang, Juanfeng Ou, Jan C. M. vanHest, Fei Peng, Yingfeng Tu
Publikováno v:
Advanced Science, Vol 7, Iss 11, Pp n/a-n/a (2020)
Abstract Nanoparticle‐based drug delivery systems with low side effects and enhanced efficacy hold great potential in the treatment of various malignancies, in particular cancer; however, they are still challenging to attain. Herein, an anticancer
Externí odkaz:
https://doaj.org/article/1ccbcf1ceb3f48b8a7b56123189e3954